SEC Filing Document

Company: Ambitious Entertainment, Inc.
Ticker: 
CIK: 1900851
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-07-17
Accession Number: 0001493152-25-011282
Exchange: 
SIC Code: 7812
SIC Description: Services-Motion Picture & Video Tape Production
URL: https://www.sec.gov/Archives/edgar/data/1900851/000149315225011282/filename1.htm

Chunk 35 of 56
Word Count: 1420
Character Count: 9145

Document Content:

are non-U.S. entities with U.S. owners), (2) the non-financial foreign entity either certifies it does not have any “substantial United States owners” (as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. Under the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. Under proposed regulations, FATCA withholding on payments of gross proceeds from the sale or other disposition of stock has been eliminated. These proposed regulations are subject to change. Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock. UNDERWRITING

have entered into an underwriting agreement with _____ as representative of the several underwriters named therein (the “Representative”)
with respect to the shares of our common stock sold in this offering. Subject to the terms and conditions of the underwriting agreement,
we have agreed to sell to the underwriters, and each underwriter named below has severally agreed to purchase from us, the number of
shares of our common stock set forth opposite its name in the following table, at the initial public offering price less the underwriting
discounts and commissions set forth on the cover page of this prospectus.

Name Number of
Shares

Total [●]

The
underwriters are offering the shares subject to their acceptance of shares from us and subject to prior sale. The underwriting agreement
provides that the obligations of the underwriters to pay for and accept delivery of the shares offered by this prospectus are subject
to the approval of certain legal matters by their counsel and to certain other conditions contained in the underwriting agreement, such
as the receipt by the underwriters of officer’s certificates and legal opinions. The underwriters are obligated to take and pay
for all of the shares offered by this prospectus if any such shares are taken. However, the underwriters are not required to take or
pay for shares covered by the underwriters’ over-allotment option described below. The underwriters reserve the right to withdraw,
cancel or modify offers to the public and to reject orders in whole or in part.

have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act and liabilities
arising from breaches of representations and warranties contained in the underwriting agreement, or to contribute to payments that the
underwriters may be required to make in respect of those liabilities.

Over-Allotment
Option

have granted the underwriters an over-allotment option, exercisable for up to [●] days from the date of this prospectus, to purchase
up to [●] additional shares of our common stock at the initial public offering price set forth on the cover page of this prospectus,
less underwriting discounts and commission, solely to cover any over-allotments, if any. The option may be exercised in whole or in part,
and may be exercised more than once, during the 45-day option period. To the extent that the option is exercised, each underwriter will
become obligated, subject to certain conditions, to purchase the same percentage of the additional shares as the number listed next to
the underwriter’s name in the preceding table bears to the total number of shares listed next to the names of all underwriters
in the preceding table. If this option is exercised in full, the total price to the public will be $[●], total underwriting discounts
and commissions will be $[●] (assuming all investors and the total net proceeds, before expenses, to us will be $[●].

Underwriting
Discounts, Commissions and Expenses

estimate that the total expenses of the offering payable by us, excluding underwriting discounts and commissions, will be approximately
$[●]. Under the underwriting agreement, we will pay fees and commissions to the underwriters equal to (i) [●]% per share,
the underwriting discount we have agreed to pay on investors in this offering introduced by the underwriters; and (ii) [●]% per
share, the underwriting discount we have agreed to pay on investors in this offering introduced by us. For purpose of the table below,
we assume all investors in this offering are introduced by the underwriters.

The
underwriters propose initially to offer the shares to the public at the public offering price set forth on the cover page of this prospectus
and to dealers at those prices less a concession not in excess of $[●] per share. If all of the shares offered by us are not sold
at the public offering price, the underwriters may change the offering price and other selling terms by means of a supplement to this
prospectus.

The
following table shows the per share price and total underwriting discounts and commissions to be paid to the underwriters. These amounts
are shown assuming both no exercise and full exercise of the underwriters’ over-allotment.

Per
Share Total
Without Over-Allotment Option Total
With Full Over-Allotment Option

Initial public
offering price $	[●] $	[●] $	[●]

Underwriting discounts
and commissions(1) $	[●] $	[●] $	[●]

Proceeds, before expenses,

(1)	Represents
an underwriting discount of [●]% of the gross proceeds of the offering, assuming all
investors in this offering are introduced by the underwriters.

have agreed to pay all of the expenses relating to the offering, including (a) all filing fees and communication expenses relating to
the registration of the shares of common stock to be sold in this offering with the Securities and Exchange Commission; (b) all fees
and expenses relating to the listing of the shares on the NYSE American and such other exchanges as the Company and Representative
together determine, including any fees charged by DTC; (c) all fees, expenses and disbursements relating to the registration or qualification
of the shares under “blue sky” or securities laws. of such states of the United States of America and other jurisdictions
designated by the Representative, including the reasonable fees and expenses of the Representative’s blue sky counsel; (d) all
fees, expenses and disbursements relating to the registration, qualification or exemption of the shares under the securities laws of
such foreign jurisdictions designated by the Representative; (e) all filing fees incurred in connection with the review of this offering
by the Financial Industry Regulatory Authority, Inc., or FINRA, (f) all fees, expenses and disbursements relating to background checks
of our officers and directors; (g) the costs of all mailing and printing of the underwriting documents as the Representative may reasonably
deem necessary; (h) the fees and expenses of the counsel to the underwriters; (i) the Representative’s actual accountable road
show expenses for the offering, and (j) the Representatives’ cost of mailing prospectuses and any other offering materials to potential
investors; (k) the costs of leather bound volumes and Lucite cube mementos in such quantities as the Representative may reasonably request;
transfer taxes; and transfer and warrant agent and registrar fees; provided that the total of expenses described in clauses (f), (g),
(h), (i), (j) and (k) shall in the aggregate not exceed [●].

have also agreed to pay, at the closing of the offering, a non-accountable expense allowance to the Representative equal to [●]%
of the gross proceeds from the offering (excluding any proceeds received upon any subsequent exercise of the over-allotment option).

estimate that the total expenses of the offering payable by us, excluding the total underwriting discount and non-accountable expense
allowance, will be approximately $[●].

Discretionary
Accounts

The
underwriters do not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.

Representative’s
Warrants

have agreed to issue to the Representative or its designees at the closing of this offering warrants to purchase the number of common
stock equal to [●]% of the aggregate number of shares sold in this offering. The warrants will be exercisable at any time and from
time to time, in whole or in part, during the four-and-a-half-year period commencing six months from the commencement of sales in this
offering. The warrants will be exercisable at a per share price equal to [●]% of the initial public offering price per share in
the offering. The warrants provide for registration rights (including a one-time demand registration right at our expense and piggyback
registration rights that, in each case, expire 5 years from the commencement of sales of this offering) and customary anti-dilution provisions
as permitted under FINRA Rule 5110(g)(8).